PATENT CLAIM ANALYSIS

Application Number: 15764730
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "004900"]

Abstract:
The disclosure is related to a method of treating a disorder, such as obesity or a condition associated with obesity, such as hyperphagia, in a subject using a melanocortin-4 receptor (MC4R) agonist.

Claim (Index 26):
The method of any of the preceding claims, wherein the subject has failed one or more previous therapies, e.g., exercise, diet, bariatric surgery or vertical banded gastroplasty, or behavioral therapies, prior to administration of the agonist, e.g., at the time the agonist is prescribed, or at the time of the first administration.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 90.0
- Lexical Diversity: 1.31034
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14775916', '14800627', '15442229', '13057966', '13074565']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8206088159521256
- 35 USC 102 Novelty (BERT): 0.5462735846975169
- Combined Prediction Score: 0.7931752928266648
- Mean Citation Score: 408.489952
- Max Citation Score: 437.57434000000006
- Similarity Product: 251.1242198597813

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test